MedPath

Bifidobacterium spp.

Generic Name
Bifidobacterium spp.
Drug Type
Biotech
Unique Ingredient Identifier
IO1WP3918D

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
Probiotics Combined with Enteral Nutrition Reduces Postoperative Infectious Complications in PD
2024/12/06
NCT06719596
Phase 1
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression
2024/03/22
NCT06325605
Not Applicable
Completed
Zhen-Hong Hu
Probiotics for Gallstones in Post-bariatric Surgery Patients
2024/03/01
NCT06287931
Not Applicable
Recruiting
Shandong Linglong Yingcheng Hospital
Hyperbilirubinemia in Full-term Neonates
2024/02/02
NCT06238349
Phase 4
Recruiting
Zhuhai Center for Maternal and Child Health Care
Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics
2023/02/16
NCT05730777
Phase 4
Not yet recruiting
Peking University Third Hospital
Effect of Probiotics on Eradication of Persistent H.Pylori Infection
2023/01/09
NCT05674864
Not Applicable
Not yet recruiting
Tanta University
Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving Immunotherapy
2022/11/17
NCT05620004
Phase 1
Recruiting
Sun Yat-sen University
Effect of Probiotics on Helicobacter Pylori Eradication
2019/07/26
NCT04034641
Phase 4
UNKNOWN
Hangzhou Grand Biologic Pharmaceutical, Inc.
Probiotics Attenuate Postoperative Cognition Decline
2019/07/12
NCT04017403
Not Applicable
UNKNOWN
RenJi Hospital
Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus
2017/12/29
NCT03386643
Phase 2
Completed
University of Sao Paulo

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Live Bifidobacterium Power
丽珠集团丽珠制药厂
国药准字S20040081
生物制品
散剂
5/27/2020
Live Bifidobacterium Capsules
丽珠集团丽珠制药厂
国药准字S10960040
生物制品
胶囊剂
5/27/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy